A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia

Schizophrenia Research

Volumn 26, Issue 2-3, 1997, Pages 227-233

  Naudin, J ^a   Capo, C ^b   Giusano, B ^b   Mege J L ^b   Azorin, J M ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cytokines; IL 6; Leukocyte activation markers; Schizophrenia; TNF Antagonists

Indexed keywords

CD14 ANTIGEN; CD23 ANTIGEN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIGENS, CD14; CHRONIC DISEASE; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKINS; LEUKOCYTES; MALE; MIDDLE AGED; RECEPTORS, IGE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; SCHIZOPHRENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030879160     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00059-5     Document Type: Article

References (34)

1. Baker I., Masserano J., Wyatt R.J. Serum cytokine concentrations in patients with schizophrenia. Schizophr. Res. 20:1996;199-203.
2. Bruce L.C., Peebles A.M.S. Clinical and experimental observations on catatonia. J. Ment. Sci. 50:1903;409-417.
3. Cavallo M.G., Pozzilli P., Thorpe R. Cytokines and autoimmunity. Clin. Exper. Immunol. 96:1994;1-7.
4. Committee on Nomenclature and Statistics, American Psychiatric Association, 1995. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, DC.
5. De Lisi L.E., Goodman S., Neckers L.M., Wyatt R.J. Lymphocyte subpopulations in schizophrenic patients. Biol. Psychiatry. 17:1982;1003-1007.
6. Descamps-Latscha B., Herbelin A., Nguyen A.T., Roux-Lombard P., Zingraff J., Moynot A., Verger C., Dahmane D., de Groote D., Jungers P., Dayer J.M. Balance between IL-1β, TNFα, and their specific inhibitors in chronic renal failure and maintenance dialysis: relationships with activation markers of T cells, B cells, and monocytes. J. Immunol. 154:1995;882-892.
7. Dinarello C.A. The biological properties of interleukin-1. Europ. Cyt. Net. 5:1994;517-531.
8. Fieve R., Blumenthal B., Little B. The relationship of atypical lymphocytes, phenothiazines, and schizophrenia. Arch. Gen. Psychiatry. 115:1966;529-534.
9. Ganguli R., McAllister C.G., Rabin B.S., Solomon W., Brar J.S., Rehn T. Alterations in interleukin and in T lymphocyte subsets in a subgroup of schizophrenics. Biol. Psychiatry. 29:1991;109A.
10. Ganguli R., Rabin B.S. Increased serum interleukin-2 receptor concentration in schizophrenic and brain-damaged subjects. Arch. Gen. Psychiatry. 46:1989;292.
11. Ganguli R., Rabin B.S., Belle S.H. Decreased interleukin-2 production in schizophrenic patients. Biol. Psychiatry. 26:1989;427-430.
12. Ganguli R., Rabin B.S., Kelly R.H., Lyte M., Ragu U. Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Ann. N.Y. Acad. Sci. 496:1987;676-685.
13. Ganguli R., Yang Z., Shurin G., Chengappa K.N.R., Brar J.S., Gubbi A.V., Rabin B.S. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatr. Res. 51:1994;1-10.
14. Girardin, E., Roux-Lombard, P., Grau, G.E., Suter, P., Gallati, H., The J5 Study Group, Dayer, J.M., 1992. Imbalance between tumor necrosis factor-α and soluble TNF receptor concentrations in severe meningococcaemia. Immunology, 76, 20-23.
15. Katila H., Appelberg B., Hurme M., Rimon R. Plasma levels of interleukin-1-β and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr. Res. 12:1994;29-34.
16. Kay S.R., Opler L.A., Lindenmayer J.P. The Positive and Negative Syndrome Scale (PANSS); rationale and standardization. Br. J. Psychiatry. 155(Suppl. 7):1989;59-65.
17. Kirch D.G. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr. Bull. 19:1993;355-370.
18. + B lymphocytes in schizophrenic patients. Arch. Gen. Psychiatry. 46:1989;890-894.
19. Maes M., Bosmans E., Calabrese J., Smith R., Meltzer H.Y. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29:1995;141-152.
20. Maes M., Scharpé S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., Cosyns P. Relationships between interleukin-6 activity, acute-phase proteins and HPA-axis function in severe depression. Psychiatr. Res. 49:1993;11-27.
21. Naudin J., Mège J.L., Azorin J.M., Dassa D. Elevated circulating levels of IL-6 in schizophrenia. Schizophr. Res. 20:1996;269-273.
22. Peltonen L. All out for chromosome 6. Nature. 378:1995;665-666.
23. Rapaport M.H., McAllister C.G., Pickar D., Nelson D.L., Paul S.M. Elevated levels of soluble interleukin-2 receptors in schizophrenia. Arch. Gen. Psychiatry. 46:1989;291-292.
24. Roux-Lombard P., Punzi L., Hasler F., Bas S., Todesco S., Gallati H., Guerne P.A., Dayer J.M. Soluble tumor necrosis factor receptors in human inflammatory sunovial fluids. Arthritis and Rheumatism. 36:1993;485-489.
25. Savino W., Dardenne M. Immune-neuroendocrine interactions. Immunol. Today. 16:1995;318-322.
26. Shintani F., Kanba S., Maruo N., Nakaki T., Nibuya M., Suzuki E., Kinoshita N., Yagi G. Serum interleukin-6 in schizophrenic patients. Life Sci. 49:1991;661-664.
27. Sirota P., Fishmall P., Elizur A., Djaldetty M. Lymphokine production in schizophrenic patients. Biol. Psychiatry. 27:1990;118A.
28. Smith R.S. Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? Med. Hypotheses. 34:1991;225-229.
29. Smith R.S. A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med. Hypotheses. 39:1992;248-257.
30. Spitzer, R.L., Williams, J.B., Gibbon, M., First, M.B., 1995. Instruction Manual for the Structured Clinical Interview for DSM-IV (SCID). Biometrics Research Division, New York State Psychiatric Institute, New York.
31. Stefanis, C.N., Theodoropoulou-Vaidaki, S., Baxevanis, C.N., Spanakos, G., Papadopoulos, N.G., Economou, M., Papamichael, M., 1994. Investigation of immune parameters in never medicated and chronically medicated schizophrenic patients. Neuropsychopharmacology 10, 35, S-80-366.
32. Tracey, K.J., 1994. Tumor Necrosis Factor α. The Cytokine Handbook, 2nd ed. Academic Press, New York, pp. 289-304.
33. Villemain F., Chatenoud L., Galinovski A., Homo-Delarche F., Ginestet D., Loo H., Zarifian E., Bach J.F. Aberrant T cell-mediated immunity in untreated schizophrenic patients. Deficient interleukin-2 production. Am. J. Psychiatry. 146:1989;609-616.
34. Yang, Z.W., Chengappa, K.N., Shurin, G., Rabin, B.S., Ganguli, R., 1992. Low IL-2 production in schizophrenic patients is correlated with the clinical state and the presence of autoantibodies. Biological Psychiatry 31, 207A